A pharmaceutical company will share revenues with indigenous people who donated their genes
When Stephane Castel first met with a group of Maori and other Pacific Islanders in New Zealand to talk about his pharmaceutical company's plans for genetic research, locals feared he might be trying to profit from community members' genes without thinking too much.Instead, Dr. Castel and his colleagues explained, the goal was to strike an unconventional deal: in exchange for trusting them with their genetic heritage, participating communities would receive a share of the company's revenues. Dr. Castel also promised not to patent any genes – as many other companies had done – but rather the drugs his company would develop from the partnership.“Many people told us it was a crazy idea and that it wouldn't work,” Dr. Castel said. But five years after that first conversation at an Indigenous h...